In vitro reconstitution of B cell receptor–antigen interactions to evaluate potential vaccine candidates
- 7 January 2016
- journal article
- research article
- Published by Springer Nature in Nature Protocols
- Vol. 11 (2) , 193-213
Abstract
This protocol describes an immunogen evaluation pipeline containing two main components that enable vaccine candidates to be rank-ordered. Predicting immune responses before vaccination is challenging because of the complexity of the governing parameters. Nevertheless, recent work has shown that B cell receptor (BCR)-antigen engagement in vitro can prove a powerful means of informing the design of antibody-based vaccines. We have developed this principle into a two-phased immunogen evaluation pipeline to rank-order vaccine candidates. In phase 1, recombinant antigens are screened for reactivity to the germline precursors that produce the antibody responses of interest. To both mimic the architecture of initial antigen engagement and facilitate rapid immunogen screening, these antibodies are expressed as membrane-anchored IgM (mIgM) in 293F indicator cells. In phase 2, the binding hits are multimerized by nanoparticle or proteoliposome display, and they are evaluated for BCR triggering in an engineered B cell line displaying the IgM sequences of interest. Key developments that complement existing methodology in this area include the following: (i) introduction of a high-throughput screening step before evaluation of more time-intensive BCR-triggering analyses; (ii) generalizable multivalent antigen-display platforms needed for BCR activation; and (iii) engineered use of a human B cell line that does not display endogenous antibody, but only ectopically expressed BCR sequences of interest. Through this pipeline, the capacity to initiate favorable antibody responses is evaluated. The entire protocol can be completed within 2.5 months.Keywords
This publication has 47 references indexed in Scilit:
- Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbsPLOS Pathogens, 2013
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep SequencingScience, 2011
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionJournal of Experimental Medicine, 2011
- Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptorProceedings of the National Academy of Sciences, 2010
- Induction of Broadly Neutralizing H1N1 Influenza Antibodies by VaccinationScience, 2010
- Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineJournal of Clinical Investigation, 2010
- Structure and function of immunoglobulinsJournal of Allergy and Clinical Immunology, 2010
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionNature Medicine, 2010
- Antibody Recognition of a Highly Conserved Influenza Virus EpitopeScience, 2009
- Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccinationProceedings of the National Academy of Sciences, 2006